Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Open Access
- 1 May 1977
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 59 (5), 819-827
- https://doi.org/10.1172/jci108704
Abstract
Urimary excretion of hydroxyprolin (Hyp) is one index of total collagen degradation, from all sources. Since some of the Hyp released from collagen may be further metabolized before it is excreted, other markers are necessary to measure collagen breakdown. Excretion of the glycosides of hydroxylysine (Hyl), glucosyl galactosyl hydroxylysine (Hy1[Gl)cGa1]), and galactosyl hydroxylysine (Hyl[Ga)]), more accurately reflects collagen metabolism since these products occur in specificratios in different tissue collagens and are themselves metabolized only to a minor degree. The ratios of total Hy1/Hyp and Hyl(GlcGal)/Hyl(Ga1) were measured in the urine of norma. subjects and of patients with Paget's disease of bone, hyperphosphatasia, and extensive thermal burns. In patients with extensive thermal burns the pattern of urinary Hy1 and its glycosides was consistent with degradation of collagen in dermis and fascia. When bone collagen degradation was dominant, the pattern of urinary metabolites reflected that source. Pagetic bone collagen has an amino acid composition similar to normal bone and Hy1(G1cGa1/Hyl(G1) of 0.396-0.743,vs. normal of 0.474+/-0.088. In untreated patients with severe Paget's disease of bone or hyperphosphatasia (urinary Hyp greater than 2.0 micronmol/mg creatinine) urinary Hyl/Hyp averaged 0.052+/-0.042 (0.042+/-0.009 in normal bone) and Hy1(G1cGa1)/Hy1(Ga1) 0.601+/-0.017 (0.47+/-0.009 in normal bone). When bone resorption was decreased sufficiently with calcitonin or disodium etidronate in these patients, both the urinary ratios of Hy1/Hyp and Hy1(G1cGa1)/Hyl(Gal) rose. In normal subjects treated with calcitonin and excreting relatively little Hyp, the ratio of Hy1/H)P approached 0.7 and Hy1(G1ycGa1)/Hy1(Ga1) approached 3.5. There increased ratios reveal the existence of a source of collagen breakdown other than skin or bone. The first subcompoent of complement, Clq, which has collagen-like sequences, relatively high amounts of Hy1, and most of the glycosylated Hy1 as Hy1(G1cGa1), could be the source of these metabolites.This publication has 24 references indexed in Scilit:
- A collagen-like amino acid sequence in a polypeptide chain of human C1q (a subcomponent of the first component of complement)Biochemical Journal, 1974
- Rheumatic manifestations of Paget's disease of boneAmerican Journal Of Medicine, 1974
- Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit seraBiochemical Journal, 1972
- Chemical studies on Clq; A modulator of immunoglobulin biologyBiochemical and Biophysical Research Communications, 1971
- Diphosphonates and Page's disease of bone.1971
- Isolation and identification of N-G,N-G- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine.1970
- Degradation of 5-hydroxylysine in the rat and in the perfused liverArchives of Biochemistry and Biophysics, 1968
- HydroxyprolinemiaNew England Journal of Medicine, 1965
- Catabolism of collagen and non-collagen protein in the rat uterus during post-partum involutionBiochemical Journal, 1962
- Quantitative and Qualitative Data on the Pigment Cells of Adult Human Epidermis1Journal of Investigative Dermatology, 1957